Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 4 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 80Breast 42Thoracic 24Genitourinary 19Sarcoma 13Head & Neck 11Gynecologic 11CNS 6Lymphoid 5Tumor-Agnostic 3Plasma cell 3Other solid neoplasm 2Endocrine 1

Conditions

Multiple Myeloma 3Recurrence 1

Interventions

Dexamethasone 374Lenalidomide 206Bortezomib 201Cyclophosphamide 178Melphalan 135Calcium Dobesilate 120daratumumab 107pomalidomide 74carfilzomib 74fludarabine phosphate 71Peripheral Blood Stem Cell Transplantation 66Thalidomide 57Filgrastim 57Mycophenolic Acid 56Busulfan 55Tacrolimus 48Granulocyte Colony-Stimulating Factor 47ixazomib 45fludarabine 45Whole-Body Irradiation 44dexamethasone acetate 36Cyclosporine 35isatuximab 34Etoposide 34Antilymphocyte Serum 32dexamethasone 21-phosphate 30elotuzumab 28auricularum 27Prednisone 27plerixafor 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoadjuvant Therapy × Plasma cell × Clear all
NCT07149857 2026-06-05

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting
60 enrolled
Plasma cell

Multiple Myeloma

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown
200 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT01852799 2018-08-10

A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Shanghai Changzheng Hospital

Phase 2 Completed
18 enrolled 7 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡